产品详情
文献和实验
相关推荐
Immunoassay Reagents for Chemistry Analyzers
Research ELISAs
Animal / Preclinical ELISAs
Antibodies
Biochemicals
Other Research Products
KAMIYA BIOMEDICAL COMPANY 由Kohji Kamiya 于1983 年3 月在加利福尼亚州千橡市创立，并于1996 年迁至华盛顿州西雅图市。我们公司的宗旨是为生命科学和医学界提供最高质量的创新实验室研究和诊断工具。 KAMIYA 是一家独立的美国公司，服务于全球市场。
自 1983 年以来，该公司的第一个产品是蛋白激酶抑制剂星形孢菌素及其类似物 K252a。 Staurosporine 是由 2015 年诺贝尔奖获得者 Satoshi Ohmura 博士于 1977 年发现的。这是第一个市售的星形孢菌素。今天，星形孢菌素是生命科学研究领域研究工具之一。
今天，KAMIYA 的生命科学产品线包括数以千计的人类和动物生物标志物检测，用于临床前测试，以及世界上最大的 ELISA 试剂盒选择之一。 KAMIYA 继续提供各种其他生命科学研究产品，包括酶抑制剂和单克隆/多克隆抗体，用于各种领域，包括细胞凋亡、多药耐药、氧化/DNA 损伤和修复、骨生物学、癌症、心脏健康、炎症、压力、肥胖和糖尿病。
1997 年，KAMIYA 推出了基于免疫比浊技术的全系列临床诊断和研究免疫分析产品，用于脂质评估、凝血、炎症、糖尿病、营养评估和血清蛋白测量。 K-ASSAY 试剂开发用于标准化学分析仪，无需混合、溶解或稀释试剂或样品，具有特殊价值。
最近，KAMIYA 推出了新的创新 K-ASSAY 化学分析仪试剂，用于胰岛素、D-二聚体、XIII 因子、血浆 FDP、血清/尿液 FDP 和总 IgE 检测。
KAMIYA 现在拥有美国所有公司中最广泛的液体血清蛋白免疫测定试剂产品线。我们为全球领先的医院、医疗中心、临床实验室、临床参考实验室、研究机构、分销商和诊断仪器公司提供临床诊断试剂。
寻找 KAMIYA BIOMEDICAL COMPANY 继续为生命科学和医学界提供创新和尖端的实验室研究和诊断工具。
KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California and relocated to Seattle, Washington in 1996. Our company's purpose is supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.
Since 1983The company's first products were protein kinase inhibitors, staurosporine and its analog, K252a. Staurosporine was discovered in 1977 by Dr. Satoshi Ohmura who is a 2015 Nobel Prize winner. This was the first commercially available staurosporine. Today, staurosporine is one of the most popular research tools in life science research fields.
Today, KAMIYA's life science product lines include thousands of human and animal biomarker assays for preclinical testing with one of the largest selections of ELISA kits in the world. KAMIYA continues to offer a variety of other life science research products including enzyme inhibitors and monoclonal / polyclonal antibodies for use in a variety of fields including apoptosis, multidrug resistance, oxidative / DNA damage and repair, bone biology, cancer, cardiac health, inflammation, stress, obesity, and diabetes.
In 1997, KAMIYA introduced a full line of clinical diagnostic and research immunoassay products for lipid assessment, coagulation, inflammation, diabetes, nutritional assessment, and serum protein measurement based on immunoturbidimetric technology. The K-ASSAY reagents were developed for use on standard chemistry analyzers, requiring no mixing, dissolving, or dilution of reagent or sample, at an exceptional value.
Recently, KAMIYA has introduced new innovative K-ASSAY chemistry analyzer reagents for Insulin, D-Dimer, Factor XIII, Plasma FDP, Serum/Urine FDP, and Total IgE testing.
KAMIYA now has the broadest product line of liquid serum protein immunoassay reagents of any company in the U.S. We supply clinical diagnostic reagents to leading hospitals, medical centers, clinical laboratories, clinical reference labs, research facilities, distributors, and diagnostic instrument companies worldwide.
Look for KAMIYA BIOMEDICAL COMPANY to continue to offer the life science and medical communities with innovative and cutting edge laboratory research and diagnostic tools.
Research ELISAs
Animal / Preclinical ELISAs
Antibodies
Biochemicals
Other Research Products
KAMIYA BIOMEDICAL COMPANY 由Kohji Kamiya 于1983 年3 月在加利福尼亚州千橡市创立，并于1996 年迁至华盛顿州西雅图市。我们公司的宗旨是为生命科学和医学界提供最高质量的创新实验室研究和诊断工具。 KAMIYA 是一家独立的美国公司，服务于全球市场。
自 1983 年以来，该公司的第一个产品是蛋白激酶抑制剂星形孢菌素及其类似物 K252a。 Staurosporine 是由 2015 年诺贝尔奖获得者 Satoshi Ohmura 博士于 1977 年发现的。这是第一个市售的星形孢菌素。今天，星形孢菌素是生命科学研究领域研究工具之一。
今天，KAMIYA 的生命科学产品线包括数以千计的人类和动物生物标志物检测，用于临床前测试，以及世界上最大的 ELISA 试剂盒选择之一。 KAMIYA 继续提供各种其他生命科学研究产品，包括酶抑制剂和单克隆/多克隆抗体，用于各种领域，包括细胞凋亡、多药耐药、氧化/DNA 损伤和修复、骨生物学、癌症、心脏健康、炎症、压力、肥胖和糖尿病。
1997 年，KAMIYA 推出了基于免疫比浊技术的全系列临床诊断和研究免疫分析产品，用于脂质评估、凝血、炎症、糖尿病、营养评估和血清蛋白测量。 K-ASSAY 试剂开发用于标准化学分析仪，无需混合、溶解或稀释试剂或样品，具有特殊价值。
最近，KAMIYA 推出了新的创新 K-ASSAY 化学分析仪试剂，用于胰岛素、D-二聚体、XIII 因子、血浆 FDP、血清/尿液 FDP 和总 IgE 检测。
KAMIYA 现在拥有美国所有公司中最广泛的液体血清蛋白免疫测定试剂产品线。我们为全球领先的医院、医疗中心、临床实验室、临床参考实验室、研究机构、分销商和诊断仪器公司提供临床诊断试剂。
寻找 KAMIYA BIOMEDICAL COMPANY 继续为生命科学和医学界提供创新和尖端的实验室研究和诊断工具。
KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California and relocated to Seattle, Washington in 1996. Our company's purpose is supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.
Since 1983The company's first products were protein kinase inhibitors, staurosporine and its analog, K252a. Staurosporine was discovered in 1977 by Dr. Satoshi Ohmura who is a 2015 Nobel Prize winner. This was the first commercially available staurosporine. Today, staurosporine is one of the most popular research tools in life science research fields.
Today, KAMIYA's life science product lines include thousands of human and animal biomarker assays for preclinical testing with one of the largest selections of ELISA kits in the world. KAMIYA continues to offer a variety of other life science research products including enzyme inhibitors and monoclonal / polyclonal antibodies for use in a variety of fields including apoptosis, multidrug resistance, oxidative / DNA damage and repair, bone biology, cancer, cardiac health, inflammation, stress, obesity, and diabetes.
In 1997, KAMIYA introduced a full line of clinical diagnostic and research immunoassay products for lipid assessment, coagulation, inflammation, diabetes, nutritional assessment, and serum protein measurement based on immunoturbidimetric technology. The K-ASSAY reagents were developed for use on standard chemistry analyzers, requiring no mixing, dissolving, or dilution of reagent or sample, at an exceptional value.
Recently, KAMIYA has introduced new innovative K-ASSAY chemistry analyzer reagents for Insulin, D-Dimer, Factor XIII, Plasma FDP, Serum/Urine FDP, and Total IgE testing.
KAMIYA now has the broadest product line of liquid serum protein immunoassay reagents of any company in the U.S. We supply clinical diagnostic reagents to leading hospitals, medical centers, clinical laboratories, clinical reference labs, research facilities, distributors, and diagnostic instrument companies worldwide.
Look for KAMIYA BIOMEDICAL COMPANY to continue to offer the life science and medical communities with innovative and cutting edge laboratory research and diagnostic tools.
北京美科美生物技术开发有限公司
代理商实名认证
钻石会员
入驻年限：11年
